Cited by 434

The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.

Mutational landscape of intrahepatic cholangiocarcinoma

Open access

Zou, Shanshan, Li, Jiarui, Zhou, Huabang, Frech, Christian, Jiang, Xiaolan, Chu, Jeffrey S. C., Zhao, Xinyin, Li, Yuqiong, Li, Qiaomei, Wang, Hui, Hu, Jingyi, Kong, Guanyi, Wu, Mengchao, Ding, Chuanfan, Chen, Nansheng, Hu, Heping·2014·Nature Communications

DOI 10.1038/ncomms6696

Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/ncomms6696

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
TGF-β SIGNAL TRANSDUCTION
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
Otto Warburg's contributions to current concepts of cancer metabolism
Koppenol, W. H., Bounds, P. L., & Dang, C. V. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3038 · Cited by 3,427
From genomics to chemical genomics: new developments in KEGG
Kanehisa, M. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj102 · Cited by 3,120
Patterns of somatic mutation in human cancer genomes
Greenman, C., Stephens, P., Smith, R., Dalgliesh, G. L., Hunter, C., Bignell, G., Davies, H., Teague, J., Butler, A., Stevens, C., et al. (2007) · Nature · doi:10.1038/nature05610 · Cited by 3,080
Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases
Xu, W., Yang, H., Liu, Y., Yang, Y., Wang, P., Kim, S.-H., Ito, S., Yang, C., Wang, P., Xiao, M.-T., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.12.014 · Cited by 2,875
The mutational landscape of lethal castration-resistant prostate cancer
Grasso, C. S., Wu, Y.-M., Robinson, D. R., Cao, X., Dhanasekaran, S. M., Khan, A. P., Quist, M. J., Jing, X., Lonigro, R. J., Brenner, J. C., et al. (2012) · Nature · doi:10.1038/nature11125 · Cited by 2,517
Mitochondria and cancer
Wallace, D. C. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3365 · Cited by 2,404
Predicting the functional impact of protein mutations: application to cancer genomics
Reva, B., Antipin, Y., & Sander, C. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr407 · Cited by 2,002
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma
Guichard, C., Amaddeo, G., Imbeaud, S., Ladeiro, Y., Pelletier, L., Maad, I. B., Calderaro, J., Bioulac-Sage, P., Letexier, M., Degos, F., et al. (2012) · Nature Genetics · doi:10.1038/ng.2256 · Cited by 1,453
Cancer Genetics and Epigenetics: Two Sides of the Same Coin?
You, J. S., & Jones, P. A. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.06.008 · Cited by 1,167
The Epidemiology of Cholangiocarcinoma
Shaib, Y., & El-Serag, H. (2004) · Seminars in Liver Disease · doi:10.1055/s-2004-828889 · Cited by 1,132
The genome of Tetranychus urticae reveals herbivorous pest adaptations
Grbić, M., Van Leeuwen, T., Clark, R. M., Rombauts, S., Rouzé, P., Grbić, V., Osborne, E. J., Dermauw, W., Thi Ngoc, P. C., Ortego, F., et al. (2011) · Nature · doi:10.1038/nature10640 · Cited by 1,115
Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma
Sung, W.-K., Zheng, H., Li, S., Chen, R., Liu, X., Li, Y., Lee, N. P., Lee, W. H., Ariyaratne, P. N., Tennakoon, C., et al. (2012) · Nature Genetics · doi:10.1038/ng.2295 · Cited by 991
Self-citation
Biliary Tract Cancers
de Groen, P. C., Gores, G. J., LaRusso, N. F., Gunderson, L. L., & Nagorney, D. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910283411807 · Cited by 955
The PTEN–PI3K pathway: of feedbacks and cross-talks
Carracedo, A., & Pandolfi, P. P. (2008) · Oncogene · doi:10.1038/onc.2008.247 · Cited by 878
Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators
Fujimoto, A., Totoki, Y., Abe, T., Boroevich, K. A., Hosoda, F., Nguyen, H. H., Aoki, M., Hosono, N., Kubo, M., Miya, F., et al. (2012) · Nature Genetics · doi:10.1038/ng.2291 · Cited by 870
Frequent Mutation of Isocitrate Dehydrogenase(IDH)1 and IDH2 in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping
Borger, D. R., Tanabe, K. K., Fan, K. C., Lopez, H. U., Fantin, V. R., Straley, K. S., Schenkein, D. P., Hezel, A. F., Ancukiewicz, M., Liebman, H. M., et al. (2012) · The Oncologist · doi:10.1634/theoncologist.2011-0386 · Cited by 728
Epigenetic reprogramming in cancer
Suvà, M. L., Riggi, N., & Bernstein, B. E. (2013) · Science · doi:10.1126/science.1230184 · Cited by 706
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas
Jiao, Y., Pawlik, T. M., Anders, R. A., Selaru, F. M., Streppel, M. M., Lucas, D. J., Niknafs, N., Guthrie, V. B., Maitra, A., Argani, P., et al. (2013) · Nature Genetics · doi:10.1038/ng.2813 · Cited by 684
Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?
Shaib, Y. H., Davila, J. A., McGlynn, K., & El-Serag, H. B. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2003.11.030 · Cited by 683
MuSiC: Identifying mutational significance in cancer genomes
Dees, N. D., Zhang, Q., Kandoth, C., Wendl, M. C., Schierding, W., Koboldt, D. C., Mooney, T. B., Callaway, M. B., Dooling, D., Mardis, E. R., et al. (2012) · Genome Research · doi:10.1101/gr.134635.111 · Cited by 677
The Spectrum of SWI/SNF Mutations, Ubiquitous in Human Cancers
Shain, A. H., & Pollack, J. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055119 · Cited by 576
Synonymous Mutations Frequently Act as Driver Mutations in Human Cancers
Supek, F., Miñana, B., Valcárcel, J., Gabaldón, T., & Lehner, B. (2014) · Cell · doi:10.1016/j.cell.2014.01.051 · Cited by 557
Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma
Kan, Z., Zheng, H., Liu, X., Li, S., Barber, T. D., Gong, Z., Gao, H., Hao, K., Willard, M. D., Xu, J., et al. (2013) · Genome Research · doi:10.1101/gr.154492.113 · Cited by 523
Self-citation
Exome sequencing identifies distinct mutational patterns in liver fluke–related and non-infection-related bile duct cancers
Chan-on, W., Nairismägi, M.-L., Ong, C. K., Lim, W. K., Dima, S., Pairojkul, C., Lim, K. H., McPherson, J. R., Cutcutache, I., Heng, H. L., et al. (2013) · Nature Genetics · doi:10.1038/ng.2806 · Cited by 497
Exome sequencing of liver fluke–associated cholangiocarcinoma
Ong, C. K., Subimerb, C., Pairojkul, C., Wongkham, S., Cutcutache, I., Yu, W., McPherson, J. R., Allen, G. E., Ng, C. C. Y., Wong, B. H., et al. (2012) · Nature Genetics · doi:10.1038/ng.2273 · Cited by 486
Circulating Tumor Cells and Circulating Tumor DNA
Alix-Panabières, C., Schwarzenbach, H., & Pantel, K. (2012) · Annual Review of Medicine · doi:10.1146/annurev-med-062310-094219 · Cited by 485
The Chd family of chromatin remodelers
Marfella, C. G. A., & Imbalzano, A. N. (2007) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2006.07.012 · Cited by 432
Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma
Li, M., Zhao, H., Zhang, X., Wood, L. D., Anders, R. A., Choti, M. A., Pawlik, T. M., Daniel, H. D., Kannangai, R., Offerhaus, G. J. A., et al. (2011) · Nature Genetics · doi:10.1038/ng.903 · Cited by 427
Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas
Wang, P., Dong, Q., Zhang, C., Kuan, P.-F., Liu, Y., Jeck, W. R., Andersen, J. B., Jiang, W., Savich, G. L., Tan, T.-X., et al. (2013) · Oncogene · doi:10.1038/onc.2012.315 · Cited by 399
Exome sequencing of hepatitis B virus–associated hepatocellular carcinoma
Huang, J., Deng, Q., Wang, Q., Li, K.-Y., Dai, J.-H., Li, N., Zhu, Z.-D., Zhou, B., Liu, X.-Y., Liu, R.-F., et al. (2012) · Nature Genetics · doi:10.1038/ng.2391 · Cited by 385
Identification of driver genes in hepatocellular carcinoma by exome sequencing
Cleary, S. P., Jeck, W. R., Zhao, X., Chen, K., Selitsky, S. R., Savich, G. L., Tan, T.-X., Wu, M. C., Getz, G., Lawrence, M. S., et al. (2013) · Hepatology · doi:10.1002/hep.26540 · Cited by 302
Self-citation
Genome-Wide Mutational Signatures of Aristolochic Acid and Its Application as a Screening Tool
Poon, S. L., Pang, S.-T., McPherson, J. R., Yu, W., Huang, K. K., Guan, P., Weng, W.-H., Siew, E. Y., Liu, Y., Heng, H. L., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006086 · Cited by 289
Mutational Signature of Aristolochic Acid Exposure as Revealed by Whole-Exome Sequencing
Hoang, M. L., Chen, C.-H., Sidorenko, V. S., He, J., Dickman, K. G., Yun, B. H., Moriya, M., Niknafs, N., Douville, C., Karchin, R., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006200 · Cited by 284
High-resolution characterization of a hepatocellular carcinoma genome
Totoki, Y., Tatsuno, K., Yamamoto, S., Arai, Y., Hosoda, F., Ishikawa, S., Tsutsumi, S., Sonoda, K., Totsuka, H., Shirakihara, T., et al. (2011) · Nature Genetics · doi:10.1038/ng.804 · Cited by 282
Hepatocellular Carcinoma: From Gene to Public Health
Montesano, R., Hainaut, P., & Wild, C. P. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.24.1844 · Cited by 269
Cancer genetics of epigenetic genes
Miremadi, A., Oestergaard, M. Z., Pharoah, P. D. P., & Caldas, C. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm021 · Cited by 249
Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinoma
Kipp, B. R., Voss, J. S., Kerr, S. E., Barr Fritcher, E. G., Graham, R. P., Zhang, L., Highsmith, W. E., Zhang, J., Roberts, L. R., Gores, G. J., et al. (2012) · Human Pathology · doi:10.1016/j.humpath.2011.12.007 · Cited by 244
Spectrum of somatic mitochondrial mutations in five cancers
Larman, T. C., DePalma, S. R., Hadjipanayis, A. G., The Cancer Genome Atlas Research Network, Protopopov, A., Zhang, J., Gabriel, S. B., Chin, L., Seidman, C. E., Kucherlapati, R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211502109 · Cited by 240
Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies
Sia, D., Tovar, V, Moeini, A., & Llovet, J. M. (2013) · Oncogene · doi:10.1038/onc.2012.617 · Cited by 235
Evidence-Based Approach to Cholangiocarcinoma: A Systematic Review of the Current Literature
Aljiffry, M., Abdulelah, A., Walsh, M., Peltekian, K., Alwayn, I., & Molinari, M. (2009) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2008.09.007 · Cited by 228
Cholangiocarcinoma
Blechacz, B. R. A., & Gores, G. J. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.11.003 · Cited by 212
Recurrent Targeted Genes of Hepatitis B Virus in the Liver Cancer Genomes Identified by a Next-Generation Sequencing–Based Approach
Ding, D., Lou, X., Hua, D., Yu, W., Li, L., Wang, J., Gao, F., Zhao, N., Ren, G., Li, L., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1003065 · Cited by 209
Induction of intrahepatic cholangiocellular carcinoma by liver-specific disruption ofSmad4 andPten in mice
Xu, X. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27282 · Cited by 207
Eph receptor–ephrin bidirectional signals that target Ras and Rho proteins
Noren, N. K., & Pasquale, E. B. (2004) · Cellular Signalling · doi:10.1016/j.cellsig.2003.10.006 · Cited by 194
Mutations of the p53 tumor suppressor gene and ras oncogenes in aflatoxin hepatocarcinogenesis
Shen, H.-M., & Ong, C.-N. (1996) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/s0165-1110(96)90005-6 · Cited by 171
Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma
Gartner, J. J., Parker, S. C. J., Prickett, T. D., Dutton-Regester, K., Stitzel, M. L., Lin, J. C., Davis, S., Simhadri, V. L., Jha, S., Katagiri, N., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304227110 · Cited by 168
Ephrins and Eph receptors in stem cells and cancer
Genander, M., & Frisén, J. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2010.08.005 · Cited by 153
The Pathobiology of Collagens in Glioma
Payne, L. S., & Huang, P. H. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0236 · Cited by 148
Cholangiocarcinoma: Epidemiology, Risk Factors, Pathogenesis, and Diagnosis
Charbel, H., & Al-Kawas, F. H. (2011) · Current Gastroenterology Reports · doi:10.1007/s11894-011-0178-8 · Cited by 128
Expression of G1-S modulators (p53, p16, p27, cyclin D1, Rb) and Smad4/Dpc4 in intrahepatic cholangiocarcinoma
Kang, Y. K., Kim, W. H., & Jang, J. J. (2002) · Human Pathology · doi:10.1053/hupa.2002.127444 · Cited by 116
EMu: probabilistic inference of mutational processes and their localization in the cancer genome
Fischer, A., Illingworth, C. J. R., Campbell, P. J., & Mustonen, V. (2013) · Genome biology · doi:10.1186/gb-2013-14-4-r39 · Cited by 106
Functional Genomic Studies: Insights into the Pathogenesis of Liver Cancer
Han, Z. (2012) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-090711-163752 · Cited by 98
Somatic mutations of mitochondrial genome in hepatocellular carcinoma
Yin, P., Wu, C.-C., Lin, J., Chi, C., Wei, Y., & Lee, H. (2009) · Mitochondrion · doi:10.1016/j.mito.2009.12.147 · Cited by 97
Effects of the TP53 p.R249S mutant on proliferation and clonogenic properties in human hepatocellular carcinoma cell lines: interaction with hepatitis B virus X protein
Gouas, D. A., Shi, H., Hautefeuille, A. H., Ortiz‐Cuaran, S., Legros, P., Szymańska, K., Galy, O., Egevad, L., Abedi‐Ardekani, B., Wiman, K. G., et al. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq118 · Cited by 72
Collagen--a necessary accomplice in the metastatic process.
Nerenberg, P. S., Salsas‐Escat, R., & Stultz, C. M. (2007) · PubMed · Cited by 40
CooVar: Co-occurring variant analyzer
Vergara, I. A., Frech, C., & Chen, N. (2012) · BMC Research Notes · doi:10.1186/1756-0500-5-615 · Cited by 37
Self-citation
ISWI chromatin remodeling in ovarian somatic and germ cells: revenge of the NURFs
Pépin, D., Vanderhyden, B. C., Picketts, D. J., & Murphy, B. D. (2007) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2007.05.004 · Cited by 35
The small GTPase N-Ras regulates extracellular matrix synthesis, proliferation and migration in fibroblasts
Calvo, I. F., Crespo, P., Santos, E., López-Novoa, J. M., & Martínez‐Salgado, C. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.07.008 · Cited by 21

Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Banales, J. M., Marin, J. J. G., Lamarca, A., Rodrigues, P. M., Khan, S. A., Roberts, L. R., Cardinale, V., Carpino, G., Andersen, J. B., Braconi, C., et al. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0310-z · Cited by 2,411
Human primary liver cancer–derived organoid cultures for disease modeling and drug screening
Broutier, L., Mastrogiovanni, G., Verstegen, M. M., Francies, H. E., Gavarró, L. M., Bradshaw, C. R., Allen, G. E., Arnes-Benito, R., Sidorova, O., Gaspersz, M. P., et al. (2017) · Nature Medicine · doi:10.1038/nm.4438 · Cited by 1,471
“Thus, EpCAM, was highly expressed in all CCs (CC-1-3) and CHCs (CHC-1-2) tumouroids and corresponding patients’ tissues, but absent on HCCs tumouroids and tissues (Fig.”
Influential
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
Banales, J. M., Cardinale, V., Carpino, G., Marzioni, M., Andersen, J. B., Invernizzi, P., Lind, G. E., Folseraas, T., Forbes, S. J., Fouassier, L., et al. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.51 · Cited by 1,376
Applications of patient-derived tumor xenograft models and tumor organoids
Yoshida, G. J. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0829-z · Cited by 471
Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians
Moris, D., Palta, M., Kim, C., Allen, P. J., Morse, M. A., & Lidsky, M. E. (2023) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21759 · Cited by 451

See all 434

Authors: Zou, S., Li, J., Zhou, H., Frech, C., Jiang, X., Chu, J. S. C., Zhao, X., Li, Y., Li, Q., Wang, H., Hu, J., Kong, G., Wu, M., Ding, C., Chen, N., & Hu, H.
Venue: Nature Communications
Publisher: Springer Science and Business Media LLC
Published: 2014-12-15
Volume: 5
Issue: 1
Pages: 5696-5696
ISSN: 2041-1723 (ISSN-L)
DOI: 10.1038/ncomms6696
OpenAlex: W2090446824
Cited by: 434
References: 61
FWCI: 17.92
Type: journal article
Language: en
Open access: bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

Mutational landscape of intrahepatic cholangiocarcinoma

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Metadata

Record

About these checks

Data sources